Liensinine- and Neferine-Induced Cardiotoxicity in Primary Neonatal Rat Cardiomyocytes and Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2016 Feb 4

PMID 26840304

Citations 13

Authors

Yangyang Yu

Shennan Sun

ShiFeng Wang

Qiao Zhang

Ming Li

Feng Lan

Shiyou Li

Chunsheng Liu

Affiliations

Soon will be listed here.

Abstract

Due to drug-induced potential congestive heart failure and irreversible dilated cardiomyopathies, preclinical evaluation of cardiac dysfunction is important to assess the safety of traditional or novel treatments. The embryos of Nelumbo nucifera Gaertner seeds are a homology of traditional Chinese medicine and food. In this study, we applied the real time cellular analysis (RTCA) Cardio system, which can real-time monitor the contractility of cardiomyocytes (CMs), to evaluate drug safety in rat neonatal CMs and human induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs). This study showed detailed biomechanical CM contractility in vitro, and provided insights into the cardiac dysfunctions associated with liensinine and neferine treatment. These effects exhibited dose and time-dependent recovery. Neferine showed stronger blocking effect in rat neonatal CMs than liensinine. In addition, the effects of liensinine and neferine were further evaluated on hiPS-CMs. Our study also indicated that both liensinine and neferine can cause disruption of calcium homeostasis. For the first time, we demonstrated the potential cardiac side effects of liensinine or neferine. While the same inhibition was observed on hiPS-CMs, more importantly, this study introduced an efficient and effective approach to evaluate the cardiotoxicity of the existing and novel drug candidates.

Citing Articles

Liensinine attenuates inflammation and oxidative stress in spleen tissue in an LPS-induced mouse sepsis model.

Wang H, Yang Y, Zhang X, Wang Y, Fan H, Shi J J Zhejiang Univ Sci B. 2023; 24(2):185-190.

PMID: 36751703 PMC: 10260283. DOI: 10.1631/jzus.B2200340.

The potential of plant extracts in cell therapy.

Li C, Cui Z, Deng S, Chen P, Li X, Yang H Stem Cell Res Ther. 2022; 13(1):472.

PMID: 36104798 PMC: 9476258. DOI: 10.1186/s13287-022-03152-z.

Pretreatment with Panaxatriol Saponin Attenuates Mitochondrial Apoptosis and Oxidative Stress to Facilitate Treatment of Myocardial Ischemia-Reperfusion Injury via the Regulation of Keap1/Nrf2 Activity.

Yao H, Xie Q, He Q, Zeng L, Long J, Gong Y Oxid Med Cell Longev. 2022; 2022:9626703.

PMID: 35669855 PMC: 9166985. DOI: 10.1155/2022/9626703.

An eIF3a gene mutation dysregulates myocardium growth with left ventricular noncompaction via the p-ERK1/2 pathway.

Ge M, Bai X, Liu A, Liu L, Tian J, Lu T Genes Dis. 2021; 8(4):545-554.

PMID: 34179316 PMC: 8209309. DOI: 10.1016/j.gendis.2020.02.003.

Hydroxysafflor Yellow A Ameliorates Myocardial Ischemia/Reperfusion Injury by Suppressing Calcium Overload and Apoptosis.

Ye J, Wang R, Wang M, Fu J, Zhang Q, Sun G Oxid Med Cell Longev. 2021; 2021:6643615.

PMID: 34093960 PMC: 8163549. DOI: 10.1155/2021/6643615.

References

Chacon E, Acosta D . Mitochondrial regulation of superoxide by Ca2+: an alternate mechanism for the cardiotoxicity of doxorubicin. Toxicol Appl Pharmacol. 1991; 107(1):117-28. DOI: 10.1016/0041-008x(91)90336-d. View

Traister A, Li M, Aafaqi S, Lu M, Arab S, Radisic M . Integrin-linked kinase mediates force transduction in cardiomyocytes by modulating SERCA2a/PLN function. Nat Commun. 2014; 5:4533. DOI: 10.1038/ncomms5533. View

Kalivendi S, Konorev E, Cunningham S, Vanamala S, Kaji E, Joseph J . Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium. Biochem J. 2005; 389(Pt 2):527-39. PMC: 1175131. DOI: 10.1042/BJ20050285. View

Athias P, Vandroux D, Tissier C, Rochette L . [Development of cardiac physiopathological models from cultured cardiomyocytes]. Ann Cardiol Angeiol (Paris). 2006; 55(2):90-9. DOI: 10.1016/j.ancard.2006.02.004. View

Wallace K . Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis. Cardiovasc Toxicol. 2007; 7(2):101-7. DOI: 10.1007/s12012-007-0008-2. View

Choi E, Chang H, Cho J, Chun H . Cytoprotective effect of anthocyanins against doxorubicin-induced toxicity in H9c2 cardiomyocytes in relation to their antioxidant activities. Food Chem Toxicol. 2007; 45(10):1873-81. DOI: 10.1016/j.fct.2007.04.003. View

De Giusti V, Correa M, Villa-Abrille M, Beltrano C, Yeves A, Chiappe de Cingolani G . The positive inotropic effect of endothelin-1 is mediated by mitochondrial reactive oxygen species. Life Sci. 2008; 83(7-8):264-71. DOI: 10.1016/j.lfs.2008.06.008. View

Birenbaum A, Tesse A, Loyer X, Michelet P, Andriantsitohaina R, Heymes C . Involvement of beta 3-adrenoceptor in altered beta-adrenergic response in senescent heart: role of nitric oxide synthase 1-derived nitric oxide. Anesthesiology. 2008; 109(6):1045-53. DOI: 10.1097/ALN.0b013e31818d7e5a. View

Adeyemi O, Roberts S, Harris J, West H, Shome S, Dewhurst M . QA interval as an indirect measure of cardiac contractility in the conscious telemeterised rat: model optimisation and evaluation. J Pharmacol Toxicol Methods. 2009; 60(2):159-66. DOI: 10.1016/j.vascn.2009.03.006. View

10.

Sugimoto Y, Furutani S, Nishimura K, Itoh A, Tanahashi T, Nakajima H . Antidepressant-like effects of neferine in the forced swimming test involve the serotonin1A (5-HT1A) receptor in mice. Eur J Pharmacol. 2010; 634(1-3):62-7. DOI: 10.1016/j.ejphar.2010.02.016. View

11.

van Erven L, Schalij M . Amiodarone: an effective antiarrhythmic drug with unusual side effects. Heart. 2010; 96(19):1593-600. DOI: 10.1136/hrt.2008.152652. View

12.

Guo L, Abrams R, Babiarz J, Cohen J, Kameoka S, Sanders M . Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Sci. 2011; 123(1):281-9. DOI: 10.1093/toxsci/kfr158. View

13.

Ma J, Guo L, Fiene S, Anson B, Thomson J, Kamp T . High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. Am J Physiol Heart Circ Physiol. 2011; 301(5):H2006-17. PMC: 4116414. DOI: 10.1152/ajpheart.00694.2011. View

14.

Xi B, Wang T, Li N, Ouyang W, Zhang W, Wu J . Functional cardiotoxicity profiling and screening using the xCELLigence RTCA Cardio System. J Lab Autom. 2011; 16(6):415-21. DOI: 10.1016/j.jala.2011.09.002. View

15.

Jonsson M, Wang Q, Becker B . Impedance-based detection of beating rhythm and proarrhythmic effects of compounds on stem cell-derived cardiomyocytes. Assay Drug Dev Technol. 2011; 9(6):589-99. PMC: 3232633. DOI: 10.1089/adt.2011.0396. View

16.

Won K, Lin H, Jung S, Cho S, Shin H, Bae Y . Antifungal miconazole induces cardiotoxicity via inhibition of APE/Ref-1-related pathway in rat neonatal cardiomyocytes. Toxicol Sci. 2012; 126(2):298-305. DOI: 10.1093/toxsci/kfr347. View

17.

Dong Z, Zhao X, Gu D, Shi Y, Zhang J, Hu X . Comparative effects of liensinine and neferine on the human ether-a-go-go-related gene potassium channel and pharmacological activity analysis. Cell Physiol Biochem. 2012; 29(3-4):431-42. DOI: 10.1159/000338497. View

18.

Sun N, Yazawa M, Liu J, Han L, Sanchez-Freire V, Abilez O . Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci Transl Med. 2012; 4(130):130ra47. PMC: 3657516. DOI: 10.1126/scitranslmed.3003552. View

19.

Nguemo F, Saric T, Pfannkuche K, Watzele M, Reppel M, Hescheler J . In vitro model for assessing arrhythmogenic properties of drugs based on high-resolution impedance measurements. Cell Physiol Biochem. 2012; 29(5-6):819-32. DOI: 10.1159/000188069. View

20.

Babiarz J, Ravon M, Sridhar S, Ravindran P, Swanson B, Bitter H . Determination of the human cardiomyocyte mRNA and miRNA differentiation network by fine-scale profiling. Stem Cells Dev. 2011; 21(11):1956-65. PMC: 4048009. DOI: 10.1089/scd.2011.0357. View